Peetz Christopher 的 Form 4 申報
Mirum Pharmaceuticals, Inc.（MIRM），2026/7/8 申報
- 申報編號
- 0001614740-26-000011
- 申報時間
- 2026/7/8 17:12 ET
- 交易日
- 2026/7/6
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 5 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $244.5 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Peetz ChristopherCIK 0001614740 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/7/6 | Common Stock | M行使選擇權取得 | +20,000 | $2.94 | +$58,720 | 214,309 | 直接 | |
| 2026/7/6 | Common Stock | S賣出處分 | −12,134 | $121.65F2 | −$1,476,101.1 | 202,175 | 直接 | |
| 2026/7/6 | Common Stock | S賣出處分 | −4,181 | $122.34F3 | −$511,503.54 | 197,994 | 直接 | |
| 2026/7/6 | Common Stock | S賣出處分 | −1,975 | $123.74F4 | −$244,386.5 | 196,019 | 直接 | |
| 2026/7/6 | Common Stock | S賣出處分 | −1,710 | $124.79F5 | −$213,390.9 | 194,309 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/7/6 | Common Stock | M行使選擇權處分 | −20,000 | $0.00 | $0 | 108,487 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The weighted average sale price for the transaction reported was $121.65, and the range of prices were between $121.11 and $122.105. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The weighted average sale price for the transaction reported was $122.34, and the range of prices were between $122.13 and $123.1125. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The weighted average sale price for the transaction reported was $123.74, and the range of prices were between $123.24 and $124.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The weighted average sale price for the transaction reported was $124.79, and the range of prices were between $124.27 and $124.94. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。